MedTrace Logo

Cardiovascular Registry of Atrial Fibrillation

NCT04456842 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2016

Last updated 2024-10-04

No results posted yet for this study

Summary

Follow a representative sample of Latin American patients diagnosed with atrial fibrillation to set data on demographic characteristics, documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death

Conditions

Interventions

OTHER

Patient Registry Data

To set data on demographic characteristics,documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death.

Sponsors & Collaborators

  • Brazilian Clinical Research Institute

    lead OTHER

Principal Investigators

  • Renato D. Lopes, MD, PhD · Instituto Brasileiro de Pesquisa Thomaz de Carvalho - BCRI

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-04
Primary Completion
2024-09-13
Completion
2024-09-30

Countries

  • Argentina
  • Brazil
  • Colombia
  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04456842 on ClinicalTrials.gov